1. OP0234 MBS2320, A NOVEL SELECTIVE MODULATOR OF IMMUNE METABOLISM, IN PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS: SAFETY, TOLERABILITY AND EFFICACY RESULTS OF A PHASE 2 STUDY. (2nd June 2020) Authors: Patel, L.; Skillern, L.; Foster, M.; Gray, A.; Leff, R.; Williams, S. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗